Immix Biopharma Inc.

NASDAQ: IMMX · Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Aug 15, 2025, 3:59 PM
2.27
0.00%
After-hours: Aug 15, 2025, 04:27 PM EDT

Immix Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 96.29K n/a n/a n/a 4.78K n/a n/a n/a -89.52M n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
79.83K 59.18K n/a 25.91K 24.3K 23.85K 3.08K 1.38K 506.00 505.00 566.00 566.00 383.00 620.00 620.00 620.00 n/a 608.00
Gross Profit
-79.83K -59.18K 48.15K -25.91K -24.3K -23.85K 1.71K -1.38K -506 -505 -89.52M -566 -383 -620 -620 -620 n/a -608
Operating Income
-6.72M -4.68M -4.99M -7.39M -4.7M -5.59M -5.37M -4.52M -3.72M -2.52M -3.79M -1.53M -1.56M -1.33M -598.34K -347.99K -243.16K -162.52K
Interest Income
104.06K 150.22K 185.85K 256.68K 306.92K 267.91K 228.57K 186.69K 128.85K 27.89K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.61M -4.53M -4.8M -7.14M -4.4M -5.32M -5.15M -4.34M -3.59M -2.49M -3.79M -1.53M -1.56M -1.33M -22.75M -401.93K -207.03K -1.02M
Net Income
-6.62M -4.54M -4.81M -7.15M -4.39M -5.26M -5.09M -4.28M -3.58M -2.5M -3.8M -1.54M -1.56M -1.33M -22.76M -403.26K -208.64K -1.02M
Selling & General & Admin
2.75M 2.71M 3.61M 2.95M 2.48M 2.36M 2.26M 2.42M 1.51M 1.2M 1.53M 837.44K 953.2K 700.51K 589.1K 318.3K 180.4K 137.68K
Research & Development
3.97M 1.98M 1.37M 4.45M 2.22M 3.25M 3.1M 2.11M 2.21M 1.32M 2.26M 695.94K 607.75K 629.53K 9.24K 29.69K 62.76K 24.84K
Other Expenses
-85.07K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
6.63M 4.68M 4.99M 7.39M 4.7M 5.6M 5.37M 4.52M 3.72M 2.52M 3.79M 1.53M 1.56M 1.33M 598.34K 347.99K 243.16K 162.52K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 497.00 n/a 109.00 388.00 44.51K 53.94K 53.87K 27.54K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 14.33K -10.44K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.71M 4.68M 4.99M 7.39M 4.7M 5.59M 5.37M 4.52M 3.72M 2.52M 3.79M 1.53M 1.56M 1.33M 598.34K 347.99K 243.16K 162.52K
Income Tax Expense
8.91K 9.82K 10.79K 11.14K 10.27K 8.84K 8.09K 6.81K 6.35K 5.17K 5.26K 1.67K 1.72K 1.62K 1.48K 1.34K 1.61K 1.59K
Shares Outstanding (Basic)
29.98M 29.7M 27.54M 29.42M 28.79M 23.44M 19.92M 18.58M 15.04M 13.9M 13.23M 13.92M 13.88M 13.83M 7.58M 7.2M 8.77M 8.77M
Shares Outstanding (Diluted)
29.98M 29.7M 27.54M 29.42M 28.79M 23.44M 19.92M 18.58M 15.04M 13.9M 13.23M 13.92M 13.88M 13.83M 7.58M 7.2M 8.77M 8.77M
EPS (Basic)
-0.22 -0.15 -0.17 -0.24 -0.15 -0.22 -0.26 -0.23 -0.24 -0.18 -0.29 -0.11 -0.11 -0.1 -3 -0.06 -0.02 -0.12
EPS (Diluted)
-0.22 -0.15 -0.17 -0.24 -0.15 -0.22 -0.26 -0.23 -0.24 -0.18 -0.29 -0.11 -0.11 -0.1 -3 -0.06 -0.02 -0.12
EBITDA
-6.72M -4.68M -4.95M -7.37M -4.68M -5.59M -5.14M -4.34M -3.72M -2.52M -3.79M -1.53M -1.56M -1.33M -22.71M -347.37K -152.54K -986.91K
EBIT
-6.61M -4.68M -4.99M -7.39M -4.7M -5.59M -5.15M -4.34M -3.72M -2.52M -3.79M -1.53M -1.56M -1.33M -22.71M -347.99K -153.16K -987.52K
Depreciation & Amortization
n/a 59.18K 41.34K 25.91K 24.3K 23.85K 3.08K 1.38K 506.00 505.00 566.00 566.00 383.00 620.00 620.00 620.00 620.00 608.00